Chemoinformaics analysis of 2,5,9-Trimethyldecane
| Molecular Weight | 184.367 | nRot | 7 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 0 |
| Exact Molecular Weight | 184.219 | nRing | 0 |
| Solubility: LogS | -6.411 | nHRing | 0 |
| Solubility: LogP | 6.276 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 40.3802 |
| nHD | 0 | BPOL | 28.0898 |
| QED | 0.528 |
| Synth | 2.48 |
| Natural Product Likeliness | 1.012 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.005 |
| HIA | 0.004 |
| CACO-2 | -4.32 |
| MDCK | 0.0000149 |
| BBB | 0.499 |
| PPB | 0.976936 |
| VDSS | 2.491 |
| FU | 0.0254644 |
| CYP1A2-inh | 0.42 |
| CYP1A2-sub | 0.284 |
| CYP2c19-inh | 0.453 |
| CYP2c19-sub | 0.873 |
| CYP2c9-inh | 0.624 |
| CYP2c9-sub | 0.958 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.048 |
| CYP3a4-inh | 0.071 |
| CYP3a4-sub | 0.166 |
| CL | 7.649 |
| T12 | 0.113 |
| hERG | 0.021 |
| Ames | 0.004 |
| ROA | 0.034 |
| SkinSen | 0.698 |
| Carcinogencity | 0.056 |
| EI | 0.98 |
| Respiratory | 0.153 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.571356 |